Trials / Completed
CompletedNCT01660568
Gemcitabine in NK/T Cell Lymphoma
Gemcitabine in Pretreated/Refractory NK/T Cell Lymphoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
We retrospectively review patients with refractory or relapsed ENKL who received a gemcitabine-containing regimen
Conditions
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2012-08-08
- Last updated
- 2013-02-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01660568. Inclusion in this directory is not an endorsement.